Bank of America Corp DE lessened its holdings in shares of Semler Scientific, Inc. (NASDAQ:SMLR - Free Report) by 84.0% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 5,231 shares of the company's stock after selling 27,407 shares during the quarter. Bank of America Corp DE owned approximately 0.06% of Semler Scientific worth $282,000 at the end of the most recent quarter.
A number of other large investors also recently made changes to their positions in the business. Global Retirement Partners LLC lifted its stake in shares of Semler Scientific by 62.5% during the 4th quarter. Global Retirement Partners LLC now owns 1,300 shares of the company's stock worth $70,000 after purchasing an additional 500 shares during the period. Kovitz Investment Group Partners LLC lifted its stake in shares of Semler Scientific by 2.2% during the 4th quarter. Kovitz Investment Group Partners LLC now owns 22,885 shares of the company's stock worth $1,236,000 after purchasing an additional 501 shares during the period. NewEdge Advisors LLC increased its holdings in shares of Semler Scientific by 318.3% during the 4th quarter. NewEdge Advisors LLC now owns 732 shares of the company's stock worth $40,000 after buying an additional 557 shares during the last quarter. BNP Paribas Financial Markets acquired a new stake in shares of Semler Scientific during the 4th quarter worth $30,000. Finally, Sanctuary Advisors LLC increased its holdings in shares of Semler Scientific by 13.2% during the 4th quarter. Sanctuary Advisors LLC now owns 5,012 shares of the company's stock worth $261,000 after buying an additional 584 shares during the last quarter. Hedge funds and other institutional investors own 49.37% of the company's stock.
Wall Street Analysts Forecast Growth
Separately, Wall Street Zen downgraded Semler Scientific from a "buy" rating to a "sell" rating in a report on Thursday, May 22nd.
Read Our Latest Analysis on Semler Scientific
Semler Scientific Trading Down 3.8%
Shares of NASDAQ SMLR opened at $29.58 on Friday. Semler Scientific, Inc. has a 12-month low of $21.77 and a 12-month high of $81.56. The company has a market cap of $329.88 million, a P/E ratio of 6.02 and a beta of 1.42. The stock has a fifty day moving average price of $35.56 and a 200 day moving average price of $45.61.
Semler Scientific (NASDAQ:SMLR - Get Free Report) last announced its quarterly earnings results on Tuesday, May 13th. The company reported ($0.76) earnings per share (EPS) for the quarter. Semler Scientific had a net margin of 72.65% and a return on equity of 50.77%. The company had revenue of $8.84 million during the quarter.
About Semler Scientific
(
Free Report)
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Recommended Stories
Want to see what other hedge funds are holding SMLR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Semler Scientific, Inc. (NASDAQ:SMLR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Semler Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.
While Semler Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.